皮质类固醇治疗难治性颅内高压:伴挫伤病灶的严重创伤性脑损伤患者的挽救性治疗反馈
单中心回顾性观察研究纳入2013年11月至2018年1月连续收治的512例重型颅脑损伤患者中的44例(8.6%)难治性颅内高压患者,给予甲泼尼龙240 mg/天持续2天,结果显示颅内压从治疗前平均21 mmHg显著降至15 mmHg以下(p<0.0001),68%患者为应答者。作者认为短期全身皮质类固醇治疗似乎可降低颅内压并减少侵入性手术需求。
要点
- 44例难治性颅内高压患者接受甲泼尼龙240 mg/天×2天,颅内压从平均21 mmHg降至<15 mmHg(p<0.0001)。
- 治疗后治疗指数负荷(TIL)显著下降,68%(30例)为应答者。
- 作者认为短期皮质类固醇似乎可降低颅内压并减少侵入性手术需求。
核心结论
- 短期全身皮质类固醇治疗继发于重型颅脑损伤的难治性颅内高压似乎是一种潜在有用且有效的治疗,可降低颅内压并减少更侵入性手术的需求。
研究设计与样本
- 单中心回顾性观察研究,纳入2013年11月至2018年1月连续收治的伴挫伤病灶且需外引流脑脊液的重型颅脑损伤难治性颅内高压患者,纳入标准为治疗指数负荷(TIL)>7。
主要发现
- 研究期间512例重型颅脑损伤患者中44例(8.6%)伴难治性颅内高压被纳入。
- 患者接受甲泼尼龙240 mg/天[120 mg, 240 mg]持续2天[1; 3],于重型颅脑损伤后3天给药。
- 治疗前难治性颅内高压患者平均颅内压为21 mmHg [19; 23],治疗后颅内压显著降至15 mmHg以下(p < 0.0001),持续至少7天。
- TIL在治疗后次日显著下降并持续至第2天,44例中68%(n=30)为应答者。
临床怎么用
- 作者认为短期全身皮质类固醇治疗似乎可作为伴挫伤病灶的重型颅脑损伤难治性颅内高压的潜在有用且有效的治疗,以降低颅内压并减少更侵入性手术的需求。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Refractory intracranial hypertension (rICH) is a severe complication among patients with severe traumatic brain injury (sTBI). Medical treatment may be insufficient, and in some cases, the only viable treatment option is decompressive hemicraniectomy. The assessment of a corticosteroid therapy against vasogenic edema secondary to severe brain injuries seems interesting to prevent this surgery in sTBI patients with rICH caused by contusional areas. METHODS: This is a monocentric retrospective observational study including all consecutive sTBI patients with contusion injuries and a rICH requiring cerebrospinal fluid drainage with external ventricular drainage between November 2013 and January 2018. Patient inclusion criterium was a therapeutic index load (TIL; an indirect measure of TBI severity) > 7. Intracranial pressure (ICP) and TIL were assessed before and 48 h after corticosteroid therapy (CTC). Then, we divided the population into two groups according to the evolution of the TIL: responders and non-responders to corticosteroid therapy. RESULTS: During the study period, 512 patients were hospitalized for sTBI, and among them, 44 (8.6%) with rICH were included. They received 240 mg per day [120 mg, 240 mg] of Solu-Medrol for 2 days [1; 3], 3 days after the sTBI. The average ICP in patients with rICH before the CTC bolus was 21 mmHg [19; 23]. After the CTC bolus, the ICP fell significantly to less than 15 mmHg (p < 0.0001) for at least 7 days. The TIL decreased significantly the day after the CTC bolus and until day 2. Among these 44 patients, 68% were included in the responder group (n = 30). DISCUSSION: Short and systemic corticosteroid therapy in patients with refractory intracranial hypertension secondary to severe traumatic brain injury seems to be a potentially useful and efficient treatment for lowering intracranial pressure and decreasing the need for more invasive surgeries.
引用
- Menat S, Jacquens A, Mathon B, et al. Corticosteroid treatment for refractory intracranial hypertension: a rescue therapy in patients with severe traumatic brain injury with contusional lesions-a feedback. Acta Neurochir (Wien). 2023. PMID: 36808006. doi:10.1007/s00701-023-05507-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。